Prandin - Repaglinide

Repaglinide (N) Prandin 0,5, 1,2 0,5-1 with meals 0.5-1 with meals NA 16 Up to 4 hours Metabolized by CYP 3A4 to inactive metabolites excreted in bile... [Pg.229]

These medications, such as repaglinide (7) (Prandin) (Rachman and Turner, 1995), have effects similar to sulfonylureas, but with fewer side effects in developing low blood sugar. Meglitinides work quickly, and the results fade rapidly as well. [Pg.119]

Benzoic acid derivatives Repaglinide (Prandin) Nateglinide (Starlix) Similar to the sulfonylureas Hypoglycemia bronchitis upper respiratory tract infections joint and back pain gastrointestinal disturbances headache... [Pg.487]

Oral 500 mg tablets Meglitinide Related Drugs Repaglinide (Prandin)... [Pg.1011]

Repaglinide (Prandin) Short-acting similar to sulfonylureas. Does not cause hypoglycemic reaction. [Pg.339]

Repaglinide (Prandin) is an oral insulin secretagogue of the meglitinide class. This agent is a derivative of benzoic acid, and its structure is unrelated to that of the sulfonylureas. [Pg.617]

Repaglinide (prandin) is an oral insulin secretagogue of the meglitinide class. [Pg.1053]

A meglitinide, repaglinide (Prandin), sulfonylurea, or nateglinide (Starlix) is prescribed to stimulate the beta cells to release more insulin into the bloodstream. [Pg.152]

EMEA public statement on repaglinide (NovoNorm/Prandin) contraindication of concomitant use of repaglinide and gemfibrozil, 21 Ivby 2003, London. Available at http //www,emea,eu,int/pdfs/human/press/pus/l 17003en.pdf (accessed 17/08/07). [Pg.490]

Prandin Tablets (Repaglinide). Daiichi Sankyo UK Ltd. UK Summary of product characteristics, October 2005. [Pg.511]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...